Peter is the Director of the Applied Health Research Centre (AHRC) at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, holds a Tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases, and is a Professor at the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a graduate of the Faculty of Medicine at the University of Bern in Switzerland, completed his training in internal medicine at various hospitals in Switzerland, and was a Research Fellow at the Department of Social Medicine at the University of Bristol, UK. Prior to joining St. Michael’s Hospital, Peter was the Director of the Institute of Primary Health Care and Professor of Primary Care and Clinical Epidemiology at the Faculty of Medicine at the University of Bern in Switzerland. He held previous appointments as Director of the Institute of Social and Preventive Medicine at the University of Bern and Founding Director of CTU Bern, the University’s clinical trials unit.
Peter is internationally renowned for his methodological work and for his clinical research on the management of cardiovascular and musculoskeletal disorders. A Fellow of the European Society of Cardiology, he has had leading roles in several major cardiovascular trials, including SIRTAX, LEADERS, FAME 2 and MATRIX, served as a member of several task forces of the European Society of Cardiology and co-authored the European guidelines on myocardial revascularization and on the management of acute myocardial infarction. Peter served as Editor of two Cochrane Review Groups, and contributed to the Cochrane Risk of bias tools for randomized and non-randomized studies. Since March 2020, he has worked nearly exclusively on clinical trials, observational studies, basic research and science communication related to COVID-19. Peter contributed to over 400 papers, which were cited more than 100,000 times. Since 2015 he has been recognized as a Highly Cited Researcher.